Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page
- ChecktodayChange DetectedThe page adds new helper labels and sections (Last verified, Last known status was, How to Read a Study Record, Common Questions, How to Join a Study) and updates the intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' with a revision bump to v3.6.0.SummaryDifference1%

- Check8 days agoChange DetectedRevision: v3.5.5 replaces the previous v3.5.4 on the page. This indicates a minor platform/template update rather than any changes to study data or content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a small metadata update rather than substantive content changes.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor update to the ClinicalTrials.gov page release rather than changes to the underlying study information.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0. This is a minor maintenance/versioning update that does not affect the study details.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.